Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 23 , ISSUE 2 ( February, 2019 ) > List of Articles

ORIGINAL ARTICLE

Molecular Characterization of Extended Spectrum â-lactamase and Carbapenemase Producing Klebsiella pneumoniae from a Tertiary Care Hospital

Beena Hosdurg Bhaskar, Shalini Shenoy Mulki, Sangeetha Joshi

Keywords : AmpC, Carbapenemase, Extended spectrum â-lactamase, Metallo â-lactamase

Citation Information : Bhaskar BH, Mulki SS, Joshi S. Molecular Characterization of Extended Spectrum â-lactamase and Carbapenemase Producing Klebsiella pneumoniae from a Tertiary Care Hospital. Indian J Crit Care Med 2019; 23 (2):61-66.

DOI: 10.5005/jp-journals-10071-23118

License: CC BY-NC 4.0

Published Online: 00-02-2019

Copyright Statement:  Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Objective: The extended-spectrum beta-lactamase (ESBL) and carbapenemase producing gram-negative bacteria among the members of Enterobacteriaceae are of major health concern globally. The present study was carried out to determine proportion and genetic characterization of ESBL and carbapenemase producing Klebsiella pneumoniae strains isolated from intensive care units of a tertiary care hospital. Materials and methods: A total of 250 non-duplicate K. pneumoniae isolates were recovered from various clinical specimens from our intensive care units from May 2014 to May 2015. Antibiotic susceptibility testing was performed as recommended by Clinical and Laboratory Standard Institute. Phenotypic identification of ESBL and carbapenemase producing isolates were confirmed by the double-disk synergy test, modified Hodge test, imipenem and imipenem-EDTA combined test, respectively. Molecular characterization of â-lactamase genes were performed by polymerase chain reaction. Results: Out of 250 Klebsiella pneumonaie, 84% isolates were ESBL producers, 66% were carbapenem resistant based on their reduced susceptibility to imipenem, meropenem and ertapenem. Among these 165 carbapenem resistant isolates, 9.7% were positive for blaNDM-1 and these isolates were also found to be positive for one or more bla genes. Co-carriage of AmpC in ESBL and carbapenem resistant isolates were 7.8% and 3.6%, respectively and were negative for blaKPC genes. Conclusion: The study indicated the prevalence of ESBLs and blaNDM-1, with additional bla genes and AmpC among the K. pneumoniae isolates in our intensive care units. NDM-1 producing Enterobacteriaceae is a growing health care problem. Detection of the prevalence of antibacterial resistance pattern helps towards improved antibiotic policy and empirical antibiotic treatment.


PDF Share
  1. Giske CG, Monnet DL, et al. ReAct-Action on antibiotic resistance. Clinical and economic impact of common multidrug-resistant gramnegative bacilli. Antimicrob Agents Chemother. 2008;52:813–821.
  2. Perez F, Endimiani A, et al. The continuing challenge of ESBLs. Curr Opin in Pharmacol.2007;7:459-469.
  3. Johann DD, Pitout DK, et al. Extended spectrum beta lactamases producing Enterobacteriaceae: an emerging public health concern. Lancet Infect Dies 2008;8:159-166.
  4. Kang CI, Kim SH, et al. Bloodstream infections due to extendedspectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae:risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother 2004; 48: 4574-4581.
  5. Lin CF, Hsu SK, et al. Genotypic detection and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a regional hospital in central Taiwan. J Med Microbiol. 2010;59: 665-671.
  6. Baby Padmini S, Appala Raju B, et al. Detection of Enterobacteriaceae producing CTX-M extended spectrum beta-lactamases from a tertiary care hospital in south India. Indian J Med Microbiol.2008; 26:163-166.
  7. Walsh TR. Emerging carbapenemases. A Global perspective. Int J Antimicrob agents 2010;36: S8-14.
  8. Nagaraj S, Chandran SP, et al. Carbapenem resistance among Escherichia coli and Klebsiellae pneumoniae in a tertiary care hospital, South India. Indian J Med Microbiol 2012; 30:93-95.
  9. Nordmann P, Naas T, et al. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis. 2011; 17:1791-1798.
  10. Yong D, Toleman MA, et al. Characterization of a new metallo-betalactamase gene, blaNDM-1, and a novel erythromycin esterase gene which was carried on a unique genetic structure in Klebsiella pneumoniae, sequence type 14 from India. Antimicrob Agents Chemother 2009; 53:5046-5054.
  11. Kumaraswamy KK, Toleman MA, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10:597- 602.
  12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, Twenty-First informational supplement. CLSI document M100-S21. Wayne, PA: CLSI; 2011.
  13. Yong D, Lee K, et al. Imipenem-EDTA disk method or differentiation of metallo-â-lactamase- producing clinical isolates of Pseudomonas spp and Acinetobacter spp. J Clin Microbiol 2002; 40:3798-3801.
  14. Coudron PE. Inhibitor based methods for detection of plasmidmediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J Clin Microbiol 2005; 43:4163-4167.
  15. Lee J H. Methicillin (Oxacillin)-Resistant Staphylococcus aureus strains isolated from Major food animals and their potential transfer to Humans. Appl Environ Microbiol 2003; 69:6489-6494.
  16. Manoharan A, Premlatha K, et al. SARI study group India. Correlation of TEM, SHV and CTX-M extended-spectrum beta lactamases among Enterobacteriaceae with their in vitro antimicrobial susceptibility. Indian J Med Microbiol 2011; 29:161-164.
  17. Nordmann P, Poirel L, et al. How to detect NDM-1 producers? J.Clin. Microbiol.2011; 49:718-721.
  18. S. Vered, SR Keren, et al. Evaluation of PCR-Based testing for surveillance of KPC-producing Carbapenem-Resistant members of the Enterobacteriaceae family. J. Clin. Microbiol 2009; 47:3261-3265
  19. Sharma M, Pathak S, et al. Prevalence and antibiogram of Extended Spectrum â-Lactamase (ESBL) producing Gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp. J Clin Diagn Res 2013;7: 173-177
  20. Hoda Hassan, B.A. Molecular characterization of extended-spectrum beta-lactamase. Producing Enterobacteriaceae in a Saudi Arabian tertiary hospital. J Infect Dev Ctries 2014;8: 282-288.
  21. Mohammed Y, Gadzama GB, et al. Characterization of Extended- Spectrum Beta-lactamase from Escherichia coli and Klebsiella Species from North Eastern Nigeria Journal of Clinical and Diagnostic Research 2016;10:7-10.
  22. Feizabadi MM, Raji N, et al. Distribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran. Iran Microb Drug Resist 2013; 16:49-53
  23. Hemalatha V, Padma M, et al. Detection of Amp C beta lactamases production in Escherichia coli and Klebsiella by an inhibitor based method. Indian J Med Res 2007;126:220-223.
  24. Manchanda V, Singh NP, et al. Molecular epidemiology of clinical isolates of AmpC producing Klebsiella pneumoniae. Indian J Med Microbiol 2006; 24:177-181.
  25. Black JA, Thomson KS, et al. Evaluation of beta-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC beta-lactamases in well characterized clinical strains of Klebsiella spp. J Clin Microbiol 2005;43:4168-4171.
  26. Gupta E, Mohanty S, et al. Emerging resistance to carbapenems in a tertiary care hospital in north India. Indian J Med Res. 2006;124:95-8.
  27. Aseem R, Shenoy S, et al. Approach to carbapenemase detection in Klebsiella pneumoniae in routine diagnostic laboratories. J Clin Diagn Res 2016; 10:24-27
  28. Oteo J, Saez D, et al. Carbapenemase-producing enterobacteriaceae in Spain in 2012. Antimicrob. Agents Chemother 2013;57:6344–47.
  29. Palacios-Baena, ZR, et al. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemaseproducing Enterobacteriaceae in Spain. J. Infect. 2016;72:152–60.
  30. Lascols C, Hackel M, et al. Increasing prevalence and dissemination of NDM-1 metallo-beta-lactamase in India: data from the SMART study (2009). J Antimicrob Chemother 2011;66:1992-7.
  31. Veeraraghavan B, Shankar C, et al. Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience. Pathogens and Global Health. 2017;111:240-46.
  32. Voulgari E, Gartzonika C, et al. The balkan region:NDM-1-producing Klebsiella pneumoniae ST11clonal strain causing outbreaks in Greece. J. Antimicrob. Chemother 2014;69: 2091–97.
  33. Dortet L, Brechard L, et al. Rapid detection of carbapenemaseproducing Enterobacteriaceae from blood cultures. Clin. Microbiol. Infect 2014;20:340–44.
  34. Sonnevend A, Ghazawi A, et al. Characterization of KPC-type carbapenemase-producing Klebsiella pneumoniae strains isolated in the Arabian Peninsula. J. Antimicrob. Chemother 2015;70:1592–93.
  35. Kazi M, Drego L, et al. Molecular characterization of carbapenemresistant Enterobacteriaceae in tertiary care laboratory in Mumbai. Eur. J. Clin. Microbiol. Infect. Dis 2015;34:467–72.
  36. Sarma JB, Bhattacharya PK, et al. Multidrug-resistant Enterobacteriaceae which include metallo-â-lactamase producers are the predominant pathogens of healthcare-associated infections in an Indian teaching hospital. Indian J Med Microbiol 2011;29:22-7.
  37. Deshpande P, Rodrigues C, et al. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: the treatment options with the carbapenems are compromised. J Assoc Physicians India 2010;58:147-9.
  38. Chacko B, Peter JV, et al. The New Delhi Metallo-Beta-Lactamases: Their origins and implications for the intensivists. J Global Infect Dis 2011;3:319.
  39. Ahmed N, Khalid S, et al. Occurrence of blaNDM Variants Among Enterobacteriaceae From a Neonatal Intensive Care Unit in a Northern India Hospital. Front Microbiol 2018;9:1-10.
  40. Samuelsen Ø, Thilesen CM, et al. Identification of NDM-1- producing Enterobacteriaceae in Norway. J Antimicrob Chemother 2011; 66:670-2.
  41. Poirel L, Revathi G, et al. Detection of NDM- 1-producing Klebsiella pneumoniae in Kenya. Antimicrob Agents Chemother 2011;55:934-36.
  42. Kanj SS, Kanafani ZA. Current concepts in the antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenemresistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin Proc 2011;86:250-59.
  43. Jeremiah S, Balaji V, et al. A possible alternative to the error prone modified Hodge test to correctly identify the carbapenemase producing Gram-negative bacteria. Indian J Med Microbiol. 2014;32(4):414.
  44. Shanthi M, Sekar U, et al. OXA-181 beta lactamase is not a major mediator of carbapenem resistance in Enterobacteriaceae.
  45. Li H, Zhang J, et al. Molecular characteristics of carbapenemaseproducing Enterobacter iaceaein China from 2008 to 2011: predominance of KPC-2enzyme. Diagn. Microbiol. Infect Dis 2013;78:63-65.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.